Trial Profile
Double-blind, Double-dummy, Randomised, Multicentre, Comparative Study on the Efficacy and Safety of Azathioprine Versus Mesalazine for Prevention of Clinical Relapses in Crohn's Disease Patients With Postoperative Moderate or Severe Endoscopic Recurrence.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Azathioprine; Mesalazine
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Dr Falk Pharma
- 10 Oct 2009 New trial record